| Total Population |
73,997,000 |
| Income Group |
Upper Middle |
| Total Deaths |
422,000 |
| Life Expectancy at birth |
Total |
75 |
| Male |
72 |
| Female |
78 |
| Cancer Mortality Profile |
|
| Age-Standardized Cancer Mortality Trends |
 |
| Cancer Incidence |
 |
| Adult Risk Factors |
Current tobacco smoking (2011 Data) |
Males |
42% |
| Females |
13% |
| Total |
27% |
| Total alcohol per capita consumption, in litres of pure alcohol (2010 Data) |
Males |
4.4 |
| Females |
0.5 |
| Total |
2 |
| Physical inactivity (2010 Data) |
Males |
27.1% |
| Females |
37.1% |
| Total |
32.3% |
| Obesity (2014 Data) |
Males |
22.6% |
| Females |
35.9% |
| Totals |
29.4% |
| Household solid fuel use (2012 Data) |
Males |
NA |
| Females |
NA |
| Total |
4% |
| Cancer Plans, Monitoring, and Surveillance |
Has an operational cancer policy/strategy/action plan |
Yes
|
| Has a cancer registry |
|
|
| Scope |
Population-based |
| Coverage |
National |
| Last Year of Data |
2008 |
| Cancer Primary Prevention Policies |
Tobacco Control |
Has an operational policy, strategy or action plan to reduce the burden of tobacco use |
Yes
|
| Smoke-free legislation |
All public places completely smoke-free (or at least 90% of the population covered by complete subnational smoke-free legislation)* |
| Tobacco dependence treatment |
National quit line, and both NRT and some cessation services cost- covered* |
| Warning labels |
Large warning with all appropriate characteristics* |
| Bans on advertising, promotion and sponsorship |
Ban on national television, radio and print media as well as on some but not all other forms of direct and/or indirect advertising |
| Tobacco taxes |
>75% of retail price is tax** |
| Overweight and obesity prevention and control |
Has an operational policy, strategy or action plan for reducing overweight/obesity |
Yes
|
| Physical inactivity prevention and control |
Has an operational policy, strategy or action plan to reduce physical inactivity and/or promote physical activity |
Yes |
| Harmful use of alcohol prevention and control |
Has an operational policy, strategy or action plan to reduce the harmful use of alcohol |
No |
| National Immunization |
Human Papillomavirus vaccination schedule |
NA |
| Hepatitis B vaccination schedule |
Birth, +1 month, +6 months |
| Hepatitis B vaccination coverage, infants |
97% |
| Cancer Screening and Early Detection |
Cervical Cancer |
Cervical cytology (PAP) |
Generally available at the public primary health care level |
| Acetic Acid Vizualization (VIA) |
Not generally available at the public primary health care level |
| Breast Cancer |
Breast palpation / clinical breast exam (CBE) |
Generally available at the public primary health care level |
| Mammogram |
Generally available at the public primary health care level |
| Colorectal Cancer |
Faecal occult blood test or faecal immunological test |
Generally available at the public primary health care level |
| Bowel cancer screening by exam or colonoscopy |
Not generally available at the public primary health care level |
| Cancer Treatment and Palliative Care |
Radiotherapy |
Generally available in the public health system |
| Total high energy teletherapy units / million inhabitants |
2 |
| Number of radiotherapy centres |
96 |
| Number of radiation oncologists |
501 |
| Chemotherapy (medicines not specified) |
Generally available in the public health system |
| Oral morphine (formulation not specified) |
Not generally available in the public health system |
| Non-methadone morphine equivalent consumption per cancer death (mg) |
NA |
| Community/home care for people with advanced stage cancer and other NCDs |
Not generally available |
| REMARKS |
* No mortality data available. Figures are based on national incidence estimates and modelled survival.
** Indicates highest possible level of achievement |
| SOURCE |
Extracted from:
WHO Cancer Country Profiles 2014 (https://www.who.int/cancer/country-profiles/tur_en.pdf?ua=1) as of 2019/05/30
|